- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Arrowhead Pharmaceuticals Inc BDR (A2RR34)
Arrowhead Pharmaceuticals Inc BDR stock price live, this page displays BVMF A2RR34 stock exchange data. View the A2RR34 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Arrowhead Pharmaceuticals Inc BDR real time stock price chart below.
What Is the Arrowhead Pharmaceuticals Inc BDR Stock Price Today?
The Arrowhead Pharmaceuticals Inc BDR stock price today is 34.08.
What Is the Stock Symbol for Arrowhead Pharmaceuticals Inc BDR?
The stock ticker symbol for Arrowhead Pharmaceuticals Inc BDR is A2RR34.
Is A2RR34 the Same as $A2RR34?
$A2RR34 is a common way to refer to the Arrowhead Pharmaceuticals Inc BDR ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Arrowhead Pharmaceuticals Inc BDR Trade On?
Arrowhead Pharmaceuticals Inc BDR is listed and trades on the B3 stock exchange.
Is Arrowhead Pharmaceuticals Inc BDR a Good Stock to Buy?
Determining whether Arrowhead Pharmaceuticals Inc BDR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Arrowhead Pharmaceuticals Inc BDR share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the A2RR34 quote. (ISIN: BRA2RRBDR009)
What Is the Arrowhead Pharmaceuticals Inc BDR Stock Price Today?
The Arrowhead Pharmaceuticals Inc BDR stock price today is 34.08.
What Is the Stock Symbol for Arrowhead Pharmaceuticals Inc BDR?
The stock ticker symbol for Arrowhead Pharmaceuticals Inc BDR is A2RR34.
Is A2RR34 the Same as $A2RR34?
$A2RR34 is a common way to refer to the Arrowhead Pharmaceuticals Inc BDR ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Arrowhead Pharmaceuticals Inc BDR Trade On?
Arrowhead Pharmaceuticals Inc BDR is listed and trades on the B3 stock exchange.
Is Arrowhead Pharmaceuticals Inc BDR a Good Stock to Buy?
Determining whether Arrowhead Pharmaceuticals Inc BDR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Arrowhead Pharmaceuticals Inc BDR share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the A2RR34 quote. (ISIN: BRA2RRBDR009)
B3
Currency in BRL
34.08
-6.88(-16.80%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.08
34.50
52 wk Range
25.48
59.95
A2RR34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.0834.50
52 wk Range
25.4859.95
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
A2RR34 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Aug 04, 2026
EPS / Forecast
-1.36 / --
Revenue / Forecast
75.25M / --
Compare A2RR34 to Peers and Sector
Metrics to compare | A2RR34 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipA2RR34PeersSector | |
|---|---|---|---|---|
P/E Ratio | −25.7x | 4.6x | −0.2x | |
PEG Ratio | 0.26 | 0.54 | 0.00 | |
Price / Book | 17.6x | 4.0x | 2.6x | |
Price / LTM Sales | 12.3x | 3.7x | 2.8x | |
Upside (Analyst Target) | - | 44.6% | 60.9% | |
Fair Value Upside | Unlock | 34.4% | 9.5% | Unlock |
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Arrowhead Pharmaceuticals BDR (A2RR34) Stock Price Today?
The Arrowhead Pharmaceuticals BDR stock price today is 34.08 BRL.
What Stock Exchange Does Arrowhead Pharmaceuticals BDR Trade On?
Arrowhead Pharmaceuticals BDR is listed and trades on the B3 Stock Exchange.
What Is the Stock Symbol for Arrowhead Pharmaceuticals BDR?
The stock symbol for Arrowhead Pharmaceuticals BDR is "A2RR34."
What Is the Arrowhead Pharmaceuticals BDR Market Cap?
As of today, Arrowhead Pharmaceuticals BDR market cap is 39.05B BRL.
What Is Arrowhead Pharmaceuticals BDR's Earnings Per Share (TTM)?
The Arrowhead Pharmaceuticals BDR EPS (TTM) is -11.78.
From a Technical Analysis Perspective, Is A2RR34 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Arrowhead Pharmaceuticals BDR Stock Split?
Arrowhead Pharmaceuticals BDR has split 0 times.
How Many Employees Does Arrowhead Pharmaceuticals BDR Have?
Arrowhead Pharmaceuticals BDR has 711 employees.
What is the current trading status of Arrowhead Pharmaceuticals BDR (A2RR34)?
As of Nov 10, 2026, Arrowhead Pharmaceuticals BDR (A2RR34) is trading at a price of 34.08 BRL, with a previous close of 40.96 BRL. The stock has fluctuated within a day range of 34.08 BRL to 34.50 BRL, while its 52-week range spans from 25.48 BRL to 59.95 BRL.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.